Related Experiment Video
Updated: May 21, 2025

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
Published on: July 22, 2016
Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance
Shiwen Cui1,2,3, Qiu Peng1,2, Qianfeng Ma1,2
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
Abstract:
RNA-binding proteins, integral in regulating RNA metabolism and gene expression, collaborate closely with non-coding RNAs, which are pivotal in post-transcriptional gene regulation. Both elements are essential for the progression of tumors. While recent research has increasingly illuminated their individual mechanisms, the intricate network interplay between them still requires further exploration. This article has provided a comprehensive review of the roles played by RNA-binding proteins and their associated non-coding RNAs in tumor biology. It delves into the intricate functions of various RNA-binding proteins in tumors, including their involvement in alternative splicing, m6A modification, alternative polyadenylation, and phase separation. Furthermore, it highlights the diverse and significant roles of different non-coding RNAs, such as microRNAs, long non-coding RNAs, and circRNAs, in tumor progression. The interaction between RNA-binding proteins and regulated non-coding RNAs is also explored, providing insights into their collective impact on metabolic reprogramming, immunity, drug resistance, metastasis, and ferroptosis. This in-depth exploration not only deepens our understanding of the mechanisms underlying tumorigenesis but also lays a foundation for developing innovative therapeutic strategies.
Insights
RNA-binding proteins and non-coding RNAs are crucial in tumor progression. This review explores their complex interactions, revealing insights into tumorigenesis and potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- RNA-binding proteins (RBPs) and non-coding RNAs (ncRNAs) are key regulators of gene expression.
- Both RBPs and ncRNAs play critical roles in tumor development and progression.
- The intricate network and collaborative functions of RBPs and ncRNAs in cancer remain incompletely understood.
Purpose of the Study:
- To provide a comprehensive review of the roles of RBPs and their associated ncRNAs in tumor biology.
- To explore the mechanisms by which RBPs and ncRNAs influence tumor progression.
- To elucidate the interactive network between RBPs and ncRNAs in various cancer hallmarks.
Main Methods:
- Literature review and synthesis of existing research findings.
- Analysis of the functions of specific RBPs in cancer-related processes (e.g., alternative splicing, m6A modification).
- Examination of the roles of diverse ncRNAs (miRNAs, lncRNAs, circRNAs) in tumorigenesis.
Main Results:
- RBPs are involved in critical cellular processes like alternative splicing, m6A modification, and phase separation in tumors.
- ncRNAs, including microRNAs, long non-coding RNAs, and circRNAs, significantly impact tumor progression.
- The interplay between RBPs and ncRNAs affects metabolic reprogramming, immunity, drug resistance, metastasis, and ferroptosis.
Conclusions:
- Understanding the collaborative functions of RBPs and ncRNAs is essential for comprehending tumorigenesis.
- The RBP-ncRNA network offers promising avenues for developing novel cancer therapeutic strategies.
- Further research into these interactions will deepen insights into cancer mechanisms and treatment possibilities.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
RNA Splicing
MicroRNAs
Regulation of Expression at Multiple Steps
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

